Devan V. Mehrotra, PhD, is Vice President, Biostatistics at Merck Research Laboratories (MRL), the R&D Division of Merck & Co., Inc. He leads a team of approximately 90 biostatisticians and data scientists supporting R&D projects in drug discovery, preclinical and clinical (early phase) development, and manufacturing. Over the past 32 years, he has made significant contributions towards the research, development, regulatory approval and commercialization of medical drugs and vaccines across a broad spectrum of therapeutic areas. He was awarded an MRL Presidential Fellowship in 2012. Dr. Mehrotra is also an Adjunct Professor of Biostatistics at the University of Pennsylvania and an elected Fellow of the American Statistical Association. He has served as a subject matter expert for the Bill and Melinda Gates Foundation (for HIV vaccine development), the U.S. National Academy of Sciences (for missing data issues in clinical trials), the Coalition for Epidemic Preparedness Innovations (for COVID-19 vaccine development), and the International Council on Harmonization (for ICH E9/R1 on estimands and sensitivity analyses in clinical trials).

Curriculum Vitae (CV) for Devan V. Mehrotra, PhD